Critical Appraisal of DNA Microarrays in Psychiatric Genomics

Biological Psychiatry

Volumn 60, Issue 2, 2006, Pages 163-176

  Mirnics, Károly ^a   Levitt, Pat ^a,b   Lewis, David A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

DNA microarray; gene expression; human brain; psychiatric disorders; transcriptome

Indexed keywords

GENE PRODUCT; GLUTAMATE DECARBOXYLASE 67; NEU DIFFERENTIATION FACTOR; PROTEIN; PROTEIN DTNBP1; PROTEIN GABRAB2; RGS PROTEIN; UNCLASSIFIED DRUG;

CADAVER; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOMICS; HUMAN; MENTAL DISEASE; MOLECULAR GENETICS; NEUROBIOLOGY; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TRANSCRIPTOMICS;

DNA; GENE EXPRESSION REGULATION; GENOMICS; HUMANS; MENTAL DISORDERS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PSYCHIATRY;

EID: 33745698337     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.02.003     Document Type: Review

References (170)

1. Addington A.M., Gornick M., Duckworth J., Sporn A., Gogtay N., Bobb A., et al. GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol Psychiatry 10 (2005) 581-588
2. Aitken A., Baxter H., Dubois T., Clokie S., Mackie S., Mitchell K., et al. Specificity of 14-3-3 isoform dimer interactions and phosphorylation. Biochem Soc Trans 30 (2002) 351-360
3. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney Jr. W.E., and Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52 (1995) 258-566
4. Albertson D.N., Pruetz B., Schmidt C.J., Kuhn D.M., Kapatos G., and Bannon M.J. Gene expression profile of the nucleus accumbens of human cocaine abusers. Evidence for dysregulation of myelin. J Neurochem 88 (2004) 1211-1219
5. Altar C.A., Laeng P., Jurata L.W., Brockman J.A., Lemire A., Bullard J., et al. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci 24 (2004) 2667-2677
6. Aston C., Jiang L., and Sokolov B.P. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res 77 (2004) 858-866
7. Aston C., Jiang L., and Sokolov B.P. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 10 (2005) 309-322
8. Ball C.A., Brazma A., Causton H., Chervitz S., Edgar R., Hingamp P., et al. Submission of microarray data to public repositories. PLoS Biol 2 (2004) E317
9. Berrettini W. Bipolar disorder and schizophrenia. Convergent molecular data. Neuromolecular Med 5 (2004) 109-117
10. Bezchlibnyk Y.B., Wang J.F., McQueen G.M., and Young L.T. Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex. J Neurochem 79 (2001) 826-834
11. Bilban M., Buehler L.K., Head S., Desoye G., and Quaranta V. Normalizing DNA microarray data. Curr Issues Mol Biol 4 (2002) 57-64
12. Black M.D. Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data. Psychopharmacology (Berl) 179 (2005) 154-163
13. Blalock E.M., Geddes J.W., Chen K.C., Porter N.M., Markesbery W.R., and Landfield P.W. Incipient Alzheimer's disease. Microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci U S A 101 (2004) 2173-2178
14. Bourgeois J.P., Goldman-Rakic P.S., and Rakic P. Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cereb Cortex 4 (1994) 78-96
15. Brazma A., Hingamp P., Quackenbush J., Sherlock G., Spellman P., Stoeckert C., et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29 (2001) 365-371
16. Brazma A., Parkinson H., Sarkans U., Shojatalab M., Vilo J., Abeygunawardena N., et al. ArrayExpress-a public repository for microarray gene expression data at the EBI. Nucleic Acids Res 31 (2003) 68-71
17. Brenner S., Johnson M., Bridgham J., Golda G., Lloyd D.H., Johnson D., et al. Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotechnol 18 (2000) 630-634
18. Browning M.D., Dudek E.M., Rapier J.L., Leonard S., and Freedman R. Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol Psychiatry 34 (1993) 529-535
19. Bunney W.E., Bunney B.G., Vawter M.P., Tomita H., Li J., Evans S.J., et al. Microarray technology. A review of new strategies to discover candidate vulnerability genes in psychiatric disorders. Am J Psychiatry 160 (2003) 657-666
20. Chen X., Dunham C., Kendler S., Wang X., O'Neill F.A., Walsh D., and Kendler K.S. Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families. Am J Med Genet B Neuropsychiatr Genet 129 (2004) 23-26
21. Chong V.Z., Young L.T., and Mishra R.K. cDNA array reveals differential gene expression following chronic neuroleptic administration. Implications of synapsin II in haloperidol treatment. J Neurochem 82 (2002) 1533-1539
22. Chowdari K.V., Mirnics K., Semwal P., Wood J., Lawrence E., Bhatia T., et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 11 (2002) 1373-1380
23. Chung C., Tallerico T., and Seeman P. Schizophrenia hippocampus has elevated expression of chondrex glycoprotein gene. Synapse 50 (2003) 29-34
24. Colangelo V., Schurr J., Ball M.J., Pelaez R.P., Bazan N.G., and Lukiw W.J. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1. Transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 70 (2002) 462-473
25. Colantuoni C., Jeon O.H., Hyder K., Chenchik A., Khimani A.H., et al. Gene expression profiling in postmortem Rett syndrome brain. Differential gene expression and patient classification. Neurobiol Dis 8 (2001) 847-865
26. Coyle J.T., Tsai G., and Goff D.C. Ionotropic glutamate receptors as therapeutic targets in schizophrenia. Curr Drug Targets CNS Neurol Disord 1 (2002) 183-189
27. Crawley J.N. Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment Retard Dev Disabil Res Rev 10 (2004) 248-258
28. Davis K.L., Stewart D.G., Friedman J.I., Buchsbaum M., Harvey P.D., Hof P.R., et al. White matter changes in schizophrenia. Evidence for myelin-related dysfunction. Arch Gen Psychiatry 60 (2003) 443-456
29. De Vries L., Zheng B., Fischer T., Elenko E., and Farquhar M.G. The regulator of G protein signaling family. Annu Rev Pharmacol Toxicol 40 (2000) 235-271
30. Dracheva S., Elhakem S.L., McGurk S.R., Davis K.L., and Haroutunian V. GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. J Neurosci Res 76 (2004) 581-592
31. Dutta R., McDonough J., Yin X., Peterson J., Chang A., Torres T., et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 59 (2006) 478-489
32. Eagleson K.L., Fairfull L.D., Salton S.R., and Levitt P. Regional differences in neurotrophin availability regulate selective expression of VGF in the developing limbic cortex. J Neurosci 21 (2001) 9315-9324
33. Eastwood S.L., Kerwin R.W., and Harrison P.J. Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia. Biol Psychiatry 41 (1997) 636-643
34. Eastwood S.L., McDonald B., Burnet P.W., Beckwith J.P., Kerwin R.W., and Harrison P.J. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Brain Res Mol Brain Res 29 (1995) 211-223
35. Evans S.J., Choudary P.V., Neal C.R., et al. Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci U S A 101 (2004) 15506-15511
36. Evans S.J., Choudary P.V., Vawter M.P., Li J., Meador-Woodruff J.H., Lopez J.F., et al. DNA microarray analysis of functionally discrete human brain regions reveals divergent transcriptional profiles. Neurobiol Dis 14 (2003) 240-250
37. Fatemi S.H., Pearce D.A., Brooks A.I., and Sidwell R.W. Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny. A potential animal model for schizophrenia and autism. Synapse 57 (2005) 91-99
38. Fatemi S.H., Stary J.M., Earle J.A., Araghi-Niknam M., and Eagan E. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum. Schizophr Res 72 (2005) 109-122
39. Feinberg I. Schizophrenia. Caused by a fault in programmed synaptic elimination during adolescence?. J Psychiatr Res 17 (1982) 319-334
40. Ferguson G.D., Anagnostaras S.G., Silva A.J., and Herschman H.R. Deficits in memory and motor performance in synaptotagmin IV mutant mice. Proc Natl Acad Sci U S A 97 (2000) 5598-5603
41. Fernandez-Chacon R., Alvarez de Toledo G., Hammer R.E., and Sudhof T.C. Analysis of SCAMP1 function in secretory vesicle exocytosis by means of gene targeting in mice. J Biol Chem 274 (1999) 32551-32554
42. Feron F., Perry C., Hirning M.H., McGrath J., and Mackay-Sim A. Altered adhesion, proliferation and death in neural cultures from adults with schizophrenia. Schizophr Res 40 (1999) 211-218
43. Galfalvy H.C., Erraji-Benchekroun L., Smyrniotopoulos P., Pavlidis P., Ellis S.P., Mann J.J., et al. Sex genes for genomic analysis in human brain. Internal controls for comparison of probe level data extraction. BMC Bioinformatics 4 (2003) 37
44. Garey L.J., Ong W.Y., Patel T.S., Kanani M., Davis A., Mortimer A.M., et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 65 (1998) 446-453
45. Ge H., Liu Z., Church G.M., and Vidal M. Correlation between transcriptome and interactome mapping data from Saccharomyces cerevisiae. Nat Genet 29 (2001) 482-486
46. Ginsberg S.D., Hemby S.E., Lee V.M., Eberwine J.H., and Trojanowski J.Q. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol 48 (2000) 77-87
47. Ginsberg SD, Che S, Wuu J, Counts SE, Mufson EJ (in press): Down regulation of trk but not p75 gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J Neurochem.
48. Gladkevich A., Kauffman H.F., and Korf J. Lymphocytes as a neural probe. Potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 28 (2004) 559-576
49. Glantz L.A., and Lewis D.A. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch Gen Psychiatry 54 (1997) 943-952
50. Glantz L.A., and Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Biol Psychiatry 57 (2000) 65-73
51. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder. A postmortem brain study. Arch Gen Psychiatry 57 (2000) 1061-1069
52. Gunther E.C., Stone D.J., Gerwien R.W., Bento P., and Heyes M.P. Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro. Proc Natl Acad Sci U S A 100 (2003) 9608-9613
53. Hack C.J. Integrated transcriptome and proteome data. The challenges ahead. Brief Funct Genomic Proteomic 3 (2004) 212-219
54. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A 98 (2001) 4746-4751
55. Harrison P.J., and Eastwood S.L. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet 352 (1998) 1669-1673
56. Hashimoto R., Straub R.E., Weickert C.S., Hyde T.M., Kleinman J.E., and Weinberger D.R. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry 9 (2004) 299-307
57. Hashimoto T., Bergen S.E., Nguyen Q.L., Xu B., Monteggia L.M., Pierri J.N., et al. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci 25 (2005) 372-383
58. Hashimoto T., Volk D.W., Eggan S.M., Mirnics K., Pierri J.N., Sun Z., et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 23 (2003) 6315-6326
59. Hata R., Masumura M., Akatsu H., Li F., Fujita H., Nagai Y., et al. Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain. Assessment by cDNA microarray. Biochem Biophys Res Commun 284 (2001) 310-316
60. Heckers S., Stone D., Walsh J., Shick J., Koul P., and Benes F.M. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch Gen Psychiatry 59 (2002) 521-529
61. Hegde P., Qi R., Abernathy K., Gay C., Dharap S., Gaspard R., et al. A concise guide to cDNA microarray analysis. [review]. Biotechniques 29 (2000) 548-550 552-554, 556 passim
62. Hemby S.E., Ginsberg S.D., Brunk B., Arnold S.E., Trojanowski J.Q., and Eberwine J.H. Gene expression profile for schizophrenia. Discrete neuron transcription patterns in the entorhinal cortex. Arch Gen Psychiatry 59 (2002) 631-640
63. Ho L., Guo Y., Spielman L., Petrescu O., Haroutunian V., Purohit D., et al. Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique. Neurosci Lett 298 (2001) 191-194
64. Hollingshead D., Lewis D.A., and Mirnics K. Platform influence on DNA microarray data in postmortem brain research. Neurobiol Dis 18 (2005) 649-655
65. Huang S., Yeo A.A., Gelbert L., Lin X., Nisenbaum L., and Bemis K.G. At what scale should microarray data be analyzed?. Am J Pharmacogenomics 4 (2004) 129-139
66. Husum H., Mikkelsen J.D., Hogg S., Mathe A.A., and Mork A. Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram. Neuropharmacology 39 (2000) 1463-1473
67. Huttenlocher P.R., and Dabholkar A.S. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol 387 (1997) 167-178
68. Impagnatiello F., Guidotti A.R., Pesold C., Dwivedi Y., Caruncho H., Pisu M.G., et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci U S A 95 (1998) 15718-15723
69. Ishikawa M., Mizukami K., Iwakiri M., Hidaka S., and Asada T. Immunohistochemical and immunoblot study of GABA(A) alpha1 and beta2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Neurosci Res 50 (2004) 77-84
70. Iwamoto K., Bundo M., and Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 14 (2005) 241-253
71. Jahn R., and Sudhof T.C. Membrane fusion and exocytosis. Ann Rev Biochem 68 (1999) 863-911
72. Janz R., Sudhof T.C., Hammer R.E., Unni V., Siegelbaum S.A., and Bolshakov V.Y. Essential roles in synaptic plasticity for synaptogyrin I and synaptophysin I. Neuron 3 (1999) 687-700
73. Kakiuchi C., Iwamoto K., Ishiwata M., Bundo M., Kasahara T., Kusumi I., et al. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat Genet 35 (2003) 171-175
74. Karson C., Griffin W., Mrak R., Sturner W., Shillcutt S., and Guggenheim F. Reduced levels of synaptic proteins in the prefrontal cortex in schizophrenia. Soc Neurosci Abstr 22 (1996) 1677
75. Karson C.N., Mrak R.E., Schluterman K.O., Sturner W.Q., Sheng J.G., and Griffin W.S. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia. A possible neurochemical basis for "hypofrontality.". Mol Psychiatry 4 (1999) 39-45
76. Katsel P., Davis K.L., and Haroutunian V. Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia. A gene ontology study. Schizophr Res 15 (2005) 157-173
77. Katsel P.L., Davis K.L., and Haroutunian V. Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease. Int Rev Neurobiol 63 (2005) 41-82
78. Keshavan M.S., Anderson S., and Pettegrew J.W. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res 28 (1994) 239-265
79. Keshavan M.S., Stanley J.A., and Pettegrew J.W. Magnetic resonance spectroscopy in schizophrenia. Methodological issues and findings-part II. Biol Psychiatry 48 (2000) 369-380
80. Konradi C., Eaton M., MacDonald M.L., Walsh J., Benes F.M., and Heckers S. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 61 (2004) 300-308
81. Konradi C., and Heckers S. Molecular aspects of glutamate dysregulation. Implications for schizophrenia and its treatment. Pharmacol Ther 97 (2003) 153-179
82. Kontkanen O., Toronen P., Lakso M., Wong G., and Castren E. Antipsychotic drug treatment induces differential gene expression in the rat cortex. J Neurochem 83 (2002) 1043-1053
83. Kromer S.A., Kessler M.S., Milfay D., Birg I.N., Bunck M., et al. Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J Neurosci 25 (2005) 4375-4384
84. Kuromitsu J., Yokoi A., Kawai T., Nagasu T., Aizawa T., Haga S., and Ikeda K. Reduced neuropeptide Y mRNA levels in the frontal cortex of people with schizophrenia and bipolar disorder. Brain Res Gene Expr Patterns 1 (2001) 17-21
85. Lazarov O., Robinson J., Tang Y.P., Hairston I.S., Korade-Mirnics Z., Lee V.M., et al. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120 (2005) 701-713
86. Leung Y.F., and Cavalieri D. Fundamentals of cDNA microarray data analysis. Trends Genet 19 (2003) 649-659
87. Lewohl J.M., Dodd P.R., Mayfield R.D., and Harris R.A. Application of DNA microarrays to study human alcoholism. J Biomed Sci 8 (2001) 28-36
88. Lewohl J.M., Wang L., Miles M.F., Zhang L., Dodd P.R., and Harris R.A. Gene expression in human alcoholism. Microarray analysis of frontal cortex. Alcohol Clin Exp Res 24 (2000) 1873-1882
89. Lo W.S., Lau C.F., Xuan Z., Chan C.F., Feng G.Y., He L., et al. Association of SNPs and haplotypes in GABAA receptor beta2 gene with schizophrenia. Mol Psychiatry 9 (2004) 603-608
90. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8 (2002) 500-508
91. Lockhart D.J., Dong H., Byrne M.C., Follettie M.T., Gallo M.V., Chee M.S., et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14 (1996) 1675-1680
92. Loring J.F., Wen X., Lee J.M., Seilhamer J., and Somogyi R. A gene expression profile of Alzheimer's disease. DNA Cell Biol 20 (2001) 683-695
93. Luo Z., and Geschwind D.H. Microarray applications in neuroscience. Neurobiol Dis 8 (2001) 183-193
94. MacDonald M.L., Eaton M.E., Dudman J.T., and Konradi C. Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat. Biol Psychiatry 57 (2005) 1041-1051
95. Marcotte E.R., Srivastava L.K., and Quirion R. cDNA microarray and proteomic approaches in the study of brain diseases. Focus on schizophrenia and Alzheimer's disease. Pharmacol Ther 100 (2003) 63-74
96. Mayfield R.D., Lewohl J.M., Dodd P.R., Herlihy A., Liu J., and Harris R.A. Patterns of gene expression are altered in the frontal and motor cortices of human alcoholics. J Neurochem 81 (2002) 802-813
97. Mayfield R.D., Liu J., Randall P.K., Lewohl J.M., Dodd P.R., and Harris R.A. Methods for the identification of differentially expressed genes in human post-mortem brain. Methods 31 (2003) 301-305
98. Maziade M., Roy M.A., Chagnon Y.C., Cliche D., Fournier J.P., Montgrain N., et al. Shared and specific susceptibility loci for schizophrenia and bipolar disorder. A dense genome scan in eastern Quebec families. Mol Psychiatry 10 (2005) 486-499
99. McCudden C.R., Hains M.D., Kimple R.J., Siderovski D.P., and Willard F.S. G-protein signaling. Back to the future. Cell Mol Life Sci 62 (2005) 551-577
100. Middleton F.A., Mirnics K., Pierri J.N., Lewis D.A., and Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 22 (2002) 2718-2729
101. Middleton F.A., Peng L., Lewis D.A., Levitt P., and Mirnics K. Altered expression of 14-3-3 genes in the prefrontal cortex of subjects with schizophrenia. Neuropsychopharmacology 30 (2005) 974-983
102. Mijalski T., Harder A., Halder T., Kersten M., Horsch M., Strom T.M., et al. Identification of coexpressed gene clusters in a comparative analysis of transcriptome and proteome in mouse tissues. Proc Natl Acad Sci U S A 102 (2005) 8621-8626
103. Mimmack M.L., Brooking J., and Bahn S. Quantitative polymerase chain reaction. Validation of microarray results from postmortem brain studies. Biol Psychiatry 55 (2004) 337-345
104. Mimmack M.L., Ryan M., Baba H., Navarro-Ruiz J., Iritani S., Faull R.L., et al. Gene expression analysis in schizophrenia. Reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc Natl Acad Sci U S A 99 (2002) 4680-4685
105. Mirnics K., Korade Z., Arion D., Lazarov O., Unger T., Macioce M., et al. Presenilin-1-dependent transcriptome changes. J Neurosci 25 (2005) 1571-1578
106. Mirnics K., Levitt P., and Lewis D.A. DNA microarray analysis of postmortem brain tissue. Int Rev Neurobiol 60 (2004) 153-181
107. Mirnics K., Middleton F.A., Lewis D.A., and Levitt P. Analysis of complex brain disorders with gene expression microarrays. Schizophrenia as a disease of the synapse. Trends Neurosci 24 (2001) 479-486
108. Mirnics K., Middleton F.A., Lewis D.A., and Levitt P. Delineating novel signature patterns of altered gene expression in schizophrenia using gene microarrays. ScientificWorldJournal 1 (2001) 114-116
109. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., and Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28 (2000) 53-67
110. Mirnics K., Middleton F.A., Stanwood G.D., Lewis D.A., and Levitt P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 6 (2001) 293-301
111. Mirnics K., and Pevsner J. Progress in the use of microarray technology to study the neurobiology of disease. Nat Neurosci 7 (2004) 434-439
112. Miska E.A., Alvarez-Saavedra E., Townsend M., et al. Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol 5 (2004) R68
113. Moghaddam B. Bringing order to the glutamate chaos in schizophrenia. Neuron 40 (2003) 881-884
114. Moises H.W., Zoega T., and Gottesman I.I. The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry 2 (2002) 8
115. Morris D.W., Rodgers A., McGhee K.A., Schwaiger S., Scully P., Quinn J., et al. Confirming RGS4 as a susceptibility gene for schizophrenia. Am J Med Genet B Neuropsychiatr Genet 125 (2004) 50-53
116. Murray R.M., Sham P., Van Os J., Zanelli J., Cannon M., and McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res 71 (2004) 405-416
117. Mycko M.P., Papoian R., Boschert U., Raine C.S., and Selmaj K.W. cDNA microarray analysis in multiple sclerosis lesions. Detection of genes associated with disease activity. Brain 126 (2003) 1048-1057
118. Newton S.S., Collier E.F., Hunsberger J., Adams D., Terwilliger R., Selvanayagam E., and Duman R.S. Gene profile of electroconvulsive seizures. Induction of neurotrophic and angiogenic factors. J Neurosci 23 (2003) 10841-10851
119. O'Neill M.J., Bleakman D., Zimmerman D.M., and Nisenbaum E.S. AMPA receptor potentiators for the treatment of CNS disorders. Curr Drug Targets CNS Neurol Disord 3 (2004) 181-194
120. Pasinetti G.M. Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia. J Neurosci Res 65 (2001) 471-476
121. Pavlidis P., Qin J., Arango V., Mann J.J., and Sibille E. Using the gene ontology for microarray data mining. A comparison of methods and application to age effects in human prefrontal cortex. Neurochem Res 29 (2004) 1213-1222
122. Petryshen T.L., Middleton F.A., Kirby A., Aldinger K.A., Purcell S., Tahl A.R., et al. Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol Psychiatry 10 (2005) 366-374 328
123. Pongrac J., Middleton F.A., Lewis D.A., Levitt P., and Mirnics K. Gene expression profiling with DNA microarrays. Advancing our understanding of psychiatric disorders. Neurochem Res 27 (2002) 1049-1063
124. Pongrac J.L., Middleton F.A., Peng L., Lewis D.A., Levitt P., and Mirnics K. Heat shock protein 12A shows reduced expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry 56 (2004) 943-950
125. Prabakaran S., Swatton J.E., Ryan M.M., Huffaker S.J., Huang J.T., Griffin J.L., et al. Mitochondrial dysfunction in schizophrenia. Evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9 (2004) 684-697 643
126. Purcell A.E., Jeon O.H., Zimmerman A.W., Blue M.E., and Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 57 (2001) 1618-1628
127. Quackenbush J. Computational analysis of microarray data. Nat Rev Genet 2 (2001) 418-427
128. Quackenbush J. Microarray data normalization and transformation. Nat Genet 32 suppl (2002) 496-501
129. Reimers M. Statistical analysis of microarray data. Addict Biol 10 (2005) 23-35
130. Rosahl T.W., Spillane D., Missler M., Herz J., Selig D.K., Wolff J.R., et al. Essential functions of synapsins I and II in synaptic vesicle regulation. Nature 375 (1995) 488-493
131. Samaco R.C., Nagarajan R.P., Braunschweig D., and LaSalle J.M. Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Hum Mol Genet 13 (2004) 629-639
132. Sattin A. The role of TRH and related peptides in the mechanism of action of ECT. J ECT 15 (1999) 76-92
133. Schena M., Shalon D., Davis R.W., and Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 (1995) 467-470
134. Selemon L.D., and Goldman-Rakic P.S. The reduced neuropil hypothesis. A circuit based model of schizophrenia. Biol Psychiatry 45 (1999) 17-25
135. Sibille E., Arango V., Galfalvy H.C., Pavlidis P., Erraji-Benchekroun L., Ellis S.P., and John Mann J. Gene expression profiling of depression and suicide in human prefrontal cortex. Neuropsychopharmacology 29 (2004) 351-361
136. Sibille E., Pavlides C., Benke D., and Toth M. Genetic inactivation of the serotonin(1A) receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety. J Neurosci 20 (2000) 2758-2765
137. Siderovski D.P., Strockbine B., and Behe C.I. Whither goest the RGS proteins?. Crit Rev Biochem Mol Biol 34 (1999) 215-251
138. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71 (2002) 877-892
139. Steinman L., and Zamvil S. Transcriptional analysis of targets in multiple sclerosis. Nat Rev Immunol 3 (2003) 483-492
140. Straub R.E., Jiang Y., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 71 (2002) 337-348
141. Sugai T., Kawamura M., Iritani S., Araki K., Makifuchi T., Imai C., et al. Prefrontal abnormality of schizophrenia revealed by DNA microarray. Impact on glial and neurotrophic gene expression. Ann N Y Acad Sci 1025 (2004) 84-91
142. Sun W., Park K.W., Choe J., Rhyu I.J., Kim I.H., Park S.K., et al. Identification of novel electroconvulsive shock-induced and activity-dependent genes in the rat brain. Biochem Biophys Res Commun 327 (2005) 848-856
143. Sutcliffe J.G., Foye P.E., Erlander M.G., Hilbush B.S., Bodzin L.J., Durham J.T., and Hasel K.W. TOGA. An automated parsing technology for analyzing expression of nearly all genes. Proc Natl Acad Sci U S A 97 (2000) 1976-1981
144. Tan P.K., Downey T.J., Spitznagel Jr. E.L., Xu P., Fu D., Dimitrov D.S., et al. Evaluation of gene expression measurements from commercial microarray platforms. Nucl. Acids. Res 31 (2003) 5676-5684
145. Tcherepanov A.A., and Sokolov B.P. Age-related abnormalities in expression of mRNAs encoding synapsin 1A, synapsin 1B, and synaptophysin in the temporal cortex of schizophrenics. J Neurosci Res 49 (1997) 639-644
146. Thompson P.M., Egbufoama S., and Vawter M.P. SNAP-25 reduction in the hippocampus of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 411-417
147. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362 (2003) 798-805
148. Tomita H., Vawter M.P., Walsh D.M., Evans S.J., Choudary P.V., Li J., et al. Effect of agonal and postmortem factors on gene expression profile. Quality control in microarray analyses of postmortem human brain. Biol Psychiatry 55 (2004) 346-352
149. Toyooka K., Muratake T., Tanaka T., Igarashi S., Watanabe H., Takeuchi H., et al. 14-3-3 protein eta chain gene (YWHAH) polymorphism and its genetic association with schizophrenia. Am J Med Genet 88 (1999) 164-167
150. Traynor J., Agarwal P., Lazzeroni L., and Francke U. Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations. BMC Med Genet 3 (2002) 12
151. Tsuang M.T., Nossova N., Yager T., Tsuang M.M., Guo S.C., Shyu K.G., et al. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder. A preliminary report. Am J Med Genet B Neuropsychiatr Genet 133 (2005) 1-5
152. Tudor M., Akbarian S., Chen R.Z., and Jaenisch R. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci U S A 99 (2002) 15536-15541
153. Vawter M.P., Barrett T., Cheadle C., Sokolov B.P., Wood III W.H., Donovan D.M., et al. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull 55 (2001) 641-650
154. Vawter M.P., Crook J.M., Hyde T.M., Kleinman J.E., Weinberger D.R., Becker K.G., and Freed W.J. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia. A preliminary study. Schizophr Res 58 (2002) 11-20
155. Vawter M.P., Evans S., Choudary P., Tomita H., Meador-Woodruff J., Molnar M., et al. Gender-specific gene expression in post-mortem human brain. Localization to sex chromosomes. Neuropsychopharmacology 29 (2004) 373-384
156. Vawter M.P., Ferran E., Galke B., Cooper K., Bunney W.E., and Byerley W. Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Schizophr Res 67 (2004) 41-52
157. Vawter M.P., Shannon Weickert C., Ferran E., Matsumoto M., Overman K., et al. Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia. Neurochem Res 29 (2004) 1245-1255
158. Vawter M.P., Thatcher L., Usen N., Hyde T.M., Kleinman J.E., and Freed W.J. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol Psychiatry 7 (2002) 571-578
159. Velculescu V.E., Zhang L., Vogelstein B., and Kinzler K.W. Serial analysis of gene expression. Science 270 (1995) 484-487
160. Volk D.W., Austin M.C., Pierri J.N., Sampson A.R., and Lewis D.A. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 57 (2000) 237-245
161. Wang H., Zhu Y.Z., Wong P.T., Farook J.M., Teo A.L., Lee L.K., and Moochhala S. cDNA microarray analysis of gene expression in anxious PVG and SD rats after cat-freezing test. Exp Brain Res 149 (2003) 413-421
162. Weickert C.S., Straub R.E., McClintock B.W., Matsumoto M., Hashimoto R., Hyde T.M., et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry 61 (2004) 544-555
163. Whitney L.W., Becker K.G., Tresser N.J., Caballero-Ramos C.I., Munson P.J., Prabhu V.V., et al. Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays. Ann Neurol 46 (1999) 425-428
164. Whitney L.W., Ludwin S.K., McFarland H.F., and Biddison W.E. Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J Neuroimmunol 121 (2001) 40-48
165. Williams N.M., Preece A., Spurlock G., Norton N., Williams H.J., McCreadie R.G., et al. Support for RGS4 as a susceptibility gene for schizophrenia. Biol Psychiatry 55 (2004) 192-195
166. Wong A.H., Macciardi F., Klempan T., Kawczynski W., Barr C.L., Lakatoo S., et al. Identification of candidate genes for psychosis in rat models, and possible association between schizophrenia and the 14-3-3eta gene. Mol Psychiatry 8 (2003) 156-166
167. Woo T.U., Walsh J.P., and Benes F.M. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 61 (2004) 649-657
168. Yao P.J., Zhu M., Pyun E.I., Brooks A.I., Therianos S., Meyers V.E., and Coleman P.D. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol Dis 12 (2003) 97-109
169. Yeo G., Holste D., Kreiman G., and Burge C.B. Variation in alternative splicing across human tissues. Genome Biol 5 (2004) R74
170. Zirlinger M., and Anderson D. Molecular dissection of the amygdala and its relevance to autism. Genes Brain Behav 2 (2003) 282-294